Latest (60) Full Text Articles (1570) Focus on Celiac Disease Article Summary

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: A phase IIb trial
Gastroenterology, 01/24/2014  Clinical Article

Zeuzem S, et al. – The authors performed a phase IIb, randomized, double–blind, placebo–controlled trial to evaluate the efficacy and safety of the combination of simeprevir, peginterferon–α2a (PegIFN), and ribavirin (RBV) in patients with hepatitis C virus (HCV) genotype–1 infection previously treated with PegIFN and RBV. In treatment–experienced patients, 12, 24, or 48 weeks simeprevir (100 mg or 150 mg once daily) in combination with 48 weeks PegIFN and RBV significantly increased rates of SVR at 24 weeks compared with patients given placebo, PegIFN, and RBV and was generally well tolerated.


  • The authors analyzed data from patients who did not respond (null response), had a partial response, or relapsed after treatment with PegIFN and RBV, randomly assigned to receive simeprevir (100 or 150 mg, once daily) for 12, 24, or 48 weeks plus PegIFN and RBV for 48 weeks (n = 396), or placebo plus PegIFN and RBV for 48 weeks (n = 66).
  • All patients were followed for 24 weeks after planned end of treatment; the primary end point was the proportion of patients with sustained virologic response (SVR; undetectable HCV RNA) at that time point.


  • Overall, rates of SVR at 24 weeks were significantly higher in the groups given simeprevir than those given placebo (61%-80% vs 23%; P < .001), regardless of prior response to PegIFN and RBV (simeprevir vs placebo: prior null response, 38%-59% vs 19%; prior partial response, 48%-86% vs 9%; prior relapse, 77%-89% vs 37%).
  • All groups had comparable numbers of adverse events; these led to discontinuation of simeprevir or placebo and/or PegIFN and RBV in 8.8% of patients given simeprevir and 4.5% of those given placebo.

► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Gastroenterology

See All >> Messages include industry-sponsored communications and special communications from PDR - powered by MDLinx

Most Popular Gastroenterology Articles

Last month's top read Top Articles of 2014

1 Garlic consumption and colorectal cancer risk in man: A systematic review and meta-analysis Public Health Nutrition, January 25, 2016    Evidence Based Medicine    Review Article

2 Coffee consumption and the risk of cirrhosis Alimentary Pharmacology and Therapeutics, January 26, 2016    Evidence Based Medicine    Review Article

3 Scientists in Barcelona discover a potential treatment for cirrhosis Institute for Research in Biomedicine (IRB Barcelona) News, January 11, 2016

4 Low-fiber diet may cause irreversible depletion of gut bacteria over generations Stanford School of Medicine News, January 26, 2016

5 Dietary carbohydrate quantity and quality in relation to obesity: A pooled analysis of three Finnish population-based studies Scandinavian Journal of Public Health, January 25, 2016    Clinical Article

6 Achilles' heel in gastric pathogen lends hope for new treatments Umeå University Faculty of Medicine News, January 18, 2016

7 Study finds how diabetes drug metformin inhibits progression of pancreatic cancer Massachusetts General Hospital, January 20, 2016

8 Large proportion of IBS patients are vitamin D deficient The University of Sheffield News, January 6, 2016

9 Hay fever medicine reduces symptoms of irritable bowel syndrome KU Leuven News, January 21, 2016

10 Eluxadoline for irritable bowel syndrome with diarrhea New England Journal of Medicine, January 22, 2016    Evidence Based Medicine    Clinical Article

11 NUS researchers discover new potential treatment for colorectal cancer National University of Singapore News, January 12, 2016

12 Mental health conditions more common among those who undergo bariatric surgery UCLA Health System, January 15, 2016

13 Could bug-busting viruses control food poisoning? University of Nottingham News, January 13, 2016

14 The missing link between obesity and a common liver disease Yale School of Medicine News, January 27, 2016

15 Unexpected health benefits of coffee revealed Monash University News, November 19, 2015

16 Common and uncommon pitfalls in pancreatic imaging: it is not always cancer Abdominal Imaging , December 30, 2015    Review Article

17 New research: Intestinal bacteria are affected by antidiabetic drugs University of Copenhagen Faculty of Health and Medical Sciences News, December 8, 2015

18 Alcohol aromatherapy eases nausea in the ER American College of Emergency Physicians News, December 15, 2015

19 Use of antibiotics in patients with Crohn's disease: A systematic review and meta-analysis Journal of Digestive Diseases, December 4, 2014    Evidence Based Medicine    Review Article

20 Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease Journal of Clinical Gastroenterology, January 8, 2016    Clinical Article

Indexed Journals in Gastroenterology: Gastroenterology, American Journal of Gastroenterology, Gutmore

Other Topics in Gastroenterology

Register now to view all our site's content (FREE)!

View Samples and Register